Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +149.7% | -6.1% | 1 / 3 | +19.9% | -5.84 pp | +9.56 pp | +8.6% | 1.71 | 17.09 | 125 | +19,9% | 16,2 | +356,7% | 17.09 | 10.02 | +70,6% |
| Pts | 12 | 0 | 4 | 8 | 0 | 12 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 10.400 (close price on 2026-10-19)EPS (TTM): 608,5
Financial charts
1.Revenue & growth
VND bn125Q2/26
1.Revenue & growth
VND bn125Q2/26
2.Profit & growth
VND bn16,2Q2/26
3.Profit mix (Penman)
VND bn47,9Q2/26
4.Margins & cost structure
%17.0%Q2/26
5.Returns & cash cycle
% · days3.1%Q2/26
6.Earnings quality & cash
VND bn-208Q2/26
7.Asset structure
VND bn1.358Q2/26
8.Funding & debt health
VND bn · times1.358Q2/26
9.Revenue backlog
VND bn0,61Q2/26
10.Valuation
times · %18,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %519Q2/26
Adjusted EPS growth, latest quarter
357%
Average adjusted EPS growth, 3 quarters
69.5%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26